Evidence map›Paper›PMID 23693155›Full record

Trial reportTrials2013

A pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial.

Dennis Thomas, Michael J Abramson, Billie Bonevski, Simone Taylor, Susan Poole, Gregory R Weeks, Michael J Dooley, Johnson George

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Interventions for smoking cessation in hospitalised patients.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Pooled it
  4. Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Trial
  5. Trial
  6. Pharmacist E-script transcription service initiated nicotine replacement therapy uptake in pre-admission clinic: A pilot study.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Distinguishing adult-onset asthma from COPD: a review and a new approach.International journal of chronic obstructive pulmonary disease · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Dennis ThomasCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University Parkville Campus, 381 Royal Parade, Parkville, VIC 3052, Australia.
Michael J Abramson
Billie Bonevski
Simone Taylor
Susan Poole
Gregory R Weeks
Michael J Dooley
Johnson George
The Alfred Hospital · AUMonash University · AUAustin Health · AUBarwon Health · AUUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntensive smoking cessation interventions initiated during hospitalisation are effective, but currently not widely available. Strategies are needed to integrate smoking cessation treatment into routine inpatient care. Pharmacist-led interventions for smoking cessation are feasible and efficacious in both ambulatory and community pharmacy settings. However, there is a lack of evidence from large scale studies of the effectiveness of pharmacist guided programs initiated during patient hospitalisation in achieving long-term abstinence. This study aims to evaluate the effectiveness of a pharmacist-led system change intervention initiated during hospitalisation in Australian public hospitals. METHODS/

designA multi-centre, randomised controlled trial will be conducted with 12 months follow-up. Smokers, 18 years or older, will be recruited from the wards of three Victorian public hospitals. Participants will be randomly assigned to a usual care or intervention group using a computer generated randomisation list. The intervention group will receive at least three smoking cessation support sessions by a trained pharmacist: the first during the hospital stay, the second on or immediately after discharge and the third within one month post-discharge. All smoking cessation medications will be provided free of charge during the hospital stay and for at least one week after discharge. Participants randomised to usual care will receive the current care routinely provided by the hospital. All measurements at baseline, discharge, one, six and 12 months will be performed by a blinded Research Assistant. The primary outcome measures are carbon monoxide validated 7-day point prevalence abstinence at six and 12 months. DISCUSSION: This is the first large scale study to develop and test a pharmacist-led system change intervention program initiated during patient hospitalisation. If successful, the program could be considered for wider implementation across other hospitals.

trial registrationACTRN12612000368831.

Indexed as

Hospitals, PublicInpatientsPatient AdmissionPharmacistsPharmacy Service, HospitalResearch DesignSmoking PreventionBiomarkersBreath TestsCarbon MonoxideClinical ProtocolsHumansPatient DischargeSingle-Blind MethodSmokingSmoking CessationBiomarkersCarbon Monoxide

Identifiers

PMID23693155
PMCPMC3664596
OpenAlexW2164572986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.